Beleggen.nl
Uitgebreid zoeken
Markt MonitorMarkt Monitor

BioPharma Terug naar discussie overzicht

CHTP - Chelsea Therapeutics International

790 Posts
Pagina: «« 1 ... 5 6 7 8 9 ... 40 »» | Laatste | Omlaag ↓
  1. ludwig mack 18 november 2011 17:45

    • ludwig mack

      Lid sinds: 30 jan 2004

      Laatste bezoek: 10 feb 2025

    • Aanbevelingen

      Ontvangen: 412

      Gegeven: 29

    •    Aantal posts: 8.675

    Chelsea Therapeutics (CHTP) is trading around $4.56. CHTP is a biotechnology company, based in North Carolina. These shares have traded in a range between $3.25 to $8.20 in the last 52 weeks. The 50-day moving average is $4.34 and the 200-day moving average is $4.44. Chelsea is pursuing an orphan drug strategy for a drug called Northera (Droxidopa) which is for the treatment of hypotension. (Yes, that's Hypotension, not hypertension.) This treatment has been approved and marketed in Japan for over 15 years, and generates about $50 million in revenue in that country. Recently, Chelsea released positive data on this drug and it caused an analyst to raise the price target to $18 due to their belief this will be approved early in 2012, see that here. I believe Chelsea is a low risk, high potential biotech stock. The new drug application for Northera could be approved in the first quarter of 2012. That is not long to wait for what could be exceptional gains.

    seekingalpha.com/article/308915-biote...
  3. ludwig mack 29 november 2011 14:38

    • ludwig mack

      Lid sinds: 30 jan 2004

      Laatste bezoek: 10 feb 2025

    • Aanbevelingen

      Ontvangen: 412

      Gegeven: 29

    •    Aantal posts: 8.675

    Chelsea Therapeutics to Present at the Piper Jaffray 23rd Annual Healthcare Conference

    CHARLOTTE, N.C., Nov. 29, 2011 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the Piper Jaffray 23rd Annual Healthcare Conference at 11:30 AM ET on November 30, 2011 at New York Palace Hotel.

    Dr. Simon Pedder, Chelsea's Chief Executive Officer, will provide a brief overview of the company's product pipeline, clinical development status, as well as the FDA's recent acceptance for filing and designation of priority review of its new drug application (NDA) for NORTHERA™ for the treatment of symptomatic neurogenic orthostatic hypotension in patients with primary autonomic failure (Parkinson's disease, multiple system atrophy and pure autonomic failure), dopamine beta hydroxylase deficiency and non-diabetic autonomic neuropathy.

    Dr. Pedder's presentation will be webcast live and archived for 90 days on Chelsea's website, www.chelseatherapeutics.com.

  4. svenhedin 29 november 2011 16:17

    • svenhedin

      Lid sinds: 20 aug 2003

      Laatste bezoek: 16 jul 2024

    • Aanbevelingen

      Ontvangen: 81

      Gegeven: 331

    •    Aantal posts: 2.948

    Chelsea Therapeutics International, Ltd. (CHTP) is a biotechnology company developing a variety of potential treatments including Northera (TM) ("Droxidopa"), which is for the treatment of hypotension as well as two clinical stage product candidates for immunological disorders, CH-1504 and CH-4051. Chelsea could receive marketing approval for Northera in the first quarter of 2012 and this would lead to the possible commercialization of Northera in the second quarter of 2012. We believe the chances for approval are very high because Northera ("Droxidopa") is currently approved and marketed in Japan for the treatment of orthostatic hypotension. This company has a solid balance sheet with about $57 million in cash. We view Chelsea as a low risk biotech stock with the potential to double or triple from current levels. In addition, the technicals are starting to look good and the stock could soon be poised for a major rally.

    Catalysts: Marketing approval for Northera (TM) from the FDA in the first quarter of 2012.
    52 week range: $3.25 to $8.20
    12 Month Target Price: $11 Long-Term Target Price: $16

    www.rallyresearch.com/Biotech_Health_...
  5. ludwig mack 29 november 2011 21:36

    • ludwig mack

      Lid sinds: 30 jan 2004

      Laatste bezoek: 10 feb 2025

    • Aanbevelingen

      Ontvangen: 412

      Gegeven: 29

    •    Aantal posts: 8.675

    Chelsea Therapeutics Internatio
    (NasdaqCM: CHTP )

    Real Time 4.83 Up 0.24 (5.23%) 3:27PM EST
    Last Trade: 4.8499
    Trade Time: 3:20PM EST
    Change: Up 0.2599 (5.66%)
    Prev Close: 4.59
    Open: 4.68
    Bid: 4.84 x 400
    Ask: 4.85 x 1800
    1y Target Est: 11.33
    Day's Range: 4.55 - 4.85
    52wk Range: 3.25 - 8.20
    Volume: 362,365
    Avg Vol (3m): 337,684
    Market Cap: 299.95M
    P/E (ttm): N/A
    EPS (ttm): -0.89
    Div & Yield: N/A (N/A)

    volume is mooi.
    gr
  6. ludwig mack 30 november 2011 16:01

    • ludwig mack

      Lid sinds: 30 jan 2004

      Laatste bezoek: 10 feb 2025

    • Aanbevelingen

      Ontvangen: 412

      Gegeven: 29

    •    Aantal posts: 8.675

    Last Trade: 5.05
    Trade Time: 9:44AM EST
    Change: Up 0.17 (3.48%)
    Prev Close: 4.88
    Open: 4.96
    Bid: 5.03 x 800
    Ask: 5.04 x 200
    1y Target Est: 11.33
    Day's Range: 4.94 - 5.0770
    52wk Range: 3.25 - 8.20
    Volume: 66,326
    Avg Vol (3m): 337,584
    Market Cap: 312.33M
    P/E (ttm): N/A
    EPS (ttm): -0.89
    Div & Yield: N/A (N/A)

    net open en al best volume en mooie prijs
  7. [verwijderd] 30 november 2011 22:24

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Na lang wachten begint de potentie eindelijk een beetje zichtbaar te worden. Naar mijn inschatting nog niet meer dan een aanloopje naar vééééél meer!!
  9. [verwijderd] 2 december 2011 16:48

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Ach, een jongetje, dat graag zijn succes wereldkundig maakt. Hij loopt het risico, in januari a.s. 200.000 aandelen geleverd te krijgen op $ 5.-- als ze lager zijn. Zijn ze hoger, dan is zijn ontvangen bedrag van $ 120.000.- pure winst.
  10. svenhedin 2 december 2011 19:26

    • svenhedin

      Lid sinds: 20 aug 2003

      Laatste bezoek: 16 jul 2024

    • Aanbevelingen

      Ontvangen: 81

      Gegeven: 331

    •    Aantal posts: 2.948


    Hier nog een uitleg:

    Re: Volatility Seller Story 2-Dec-11 12:15 pm

    The trader has sold put options at $5 with the
    anticipation that the stock will not go below
    that price. If it stays above or at $5 by the third
    Friday of Jan 12, he pockets the premium. This has
    no effect on CHTP pps although it is a positive bet
    on CHTP's ability to stay above $5.
  12. svenhedin 2 december 2011 19:30

    • svenhedin

      Lid sinds: 20 aug 2003

      Laatste bezoek: 16 jul 2024

    • Aanbevelingen

      Ontvangen: 81

      Gegeven: 331

    •    Aantal posts: 2.948



    De laatste link werkt met Search: CHTP

    Droxidopa/Carbidopa for Fibromyalgia 2-Dec-11 10:51 am Since data from the Phase II Droxidopa/Carbidopa trial is likely the next news impacting CHTP, here are a few links that relate to Drox/Carbidopa for Fibro:

    Link to initial trial approval in UK that describes (in layman's terms) what they hope to accomplish:

    www.fibroaction.org/News/Droxidop...

    Link to the trial at ClinicalTrials.gov (note 11/14 completion):

    clinicaltrials.gov/ct2/show/NCT01...

    Link to report from Data Monitoring Committee issuing go ahead for trial, focusing on 7 drox/carb combination arms (7/7/2011):

    www.91outcomes.com/2010/07/fibrom...!...

    Link to issuance of patent for Drox alone or in combination for treatment of Fibro (9/6/2011):

    www.marketwatch.com/story/chelsea...

    That brings us to where we sit today, awaiting hopefully positive results for the Droxidopa/Carbidopa combination therapy arms of the study by YE 2011.


  13. ludwig mack 2 december 2011 21:56

    • ludwig mack

      Lid sinds: 30 jan 2004

      Laatste bezoek: 10 feb 2025

    • Aanbevelingen

      Ontvangen: 412

      Gegeven: 29

    •    Aantal posts: 8.675

    quote:

    svenhedin schreef op 2 december 2011 19:30:

    De laatste link werkt met Search: CHTP

    Droxidopa/Carbidopa for Fibromyalgia 2-Dec-11 10:51 am Since data from the Phase II Droxidopa/Carbidopa trial is likely the next news impacting CHTP, here are a few links that relate to Drox/Carbidopa for Fibro:

    Link to initial trial approval in UK that describes (in layman's terms) what they hope to accomplish:

    www.fibroaction.org/News/Droxidop...

    Link to the trial at ClinicalTrials.gov (note 11/14 completion):

    clinicaltrials.gov/ct2/show/NCT01...

    Link to report from Data Monitoring Committee issuing go ahead for trial, focusing on 7 drox/carb combination arms (7/7/2011):

    www.91outcomes.com/2010/07/fibrom...!...

    Link to issuance of patent for Drox alone or in combination for treatment of Fibro (9/6/2011):

    www.marketwatch.com/story/chelsea...

    That brings us to where we sit today, awaiting hopefully positive results for the Droxidopa/Carbidopa combination therapy arms of the study by YE 2011.



    eerste twee en de laatste werken niet meer.
    ok, gr
  14. ludwig mack 2 december 2011 21:57

    • ludwig mack

      Lid sinds: 30 jan 2004

      Laatste bezoek: 10 feb 2025

    • Aanbevelingen

      Ontvangen: 412

      Gegeven: 29

    •    Aantal posts: 8.675

    overweeg om nog bij te kopen, maar aarzel;
    nu gewoon is afwachten wat er gebeurt en niet de zenuwen .....
    wat ik van de zomer bij daling verkocht niet meer teruggekocht.
    gr
  15. ludwig mack 2 december 2011 22:02

    • ludwig mack

      Lid sinds: 30 jan 2004

      Laatste bezoek: 10 feb 2025

    • Aanbevelingen

      Ontvangen: 412

      Gegeven: 29

    •    Aantal posts: 8.675

    quote:

    oudje schreef op 2 december 2011 16:48:

    Ach, een jongetje, dat graag zijn succes wereldkundig maakt. Hij loopt het risico, in januari a.s. 200.000 aandelen geleverd te krijgen op $ 5.-- als ze lager zijn. Zijn ze hoger, dan is zijn ontvangen bedrag van $ 120.000.- pure winst.
    en wanneer nieuws?
    eerst kwartaal, dus in ieder geval na vervaldatum put.
    gr
  17. [verwijderd] 5 december 2011 08:30

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    6 Undervalued Stocks With New Insider Buying.

    Chelsea Therapeutics (CHTP) is trading around $5.45. Chelsea is a biotechnology company, based in North Carolina. These shares have traded in a range between $3.25 to $8.20 in the last 52 weeks. The 50-day moving average is $4.41 and the 200-day moving average is $4.43. Chelsea is pursuing an orphan drug strategy for a drug called Northera (Droxidopa) which is for the treatment of hypotension. (Yes, that's Hypotension, not hypertension.) This treatment has been approved and marketed in Japan for over 15 years, and generates about $50 million in revenue in that country. The new drug application for Northera could be approved in the first quarter of 2012. That is not long to wait for what could be exceptional gains in this low risk, high potential biotech. This is one of my favorite biotechs, and the chart looks great now too. A director recently bought 45,141. seekingalpha.com/article/311743-6-und...
  18. [verwijderd] 5 december 2011 19:43

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Vrijdag 25/11 gesloten op $ 4.35

    Vandaag de zesde achtereenvolgende stijging?

    Koers nu $ 5.74, een plus van bijna 32%.

    Denken we straks in februari/maart, dat dit nog slechts een beginnetje is?
  21. [verwijderd] 13 december 2011 22:43

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Gisteren 3 centjes winst + waardedaling euro;
    Vandaag 5 cent verlies, ruimschoots gecompenseerd door de winnende dollar.
    Kortom: goed resultaat in twee nogal wankele dagen.

    Seeking Alpha blijft aardig bezig!
790 Posts
Pagina: «« 1 ... 5 6 7 8 9 ... 40 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beleggen.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.016
AB InBev 2 5.495
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.616
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.616
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.747
Aedifica 3 912
Aegon 3.258 322.710
AFC Ajax 538 7.088
Affimed NV 2 6.296
ageas 5.844 109.891
Agfa-Gevaert 14 2.049
Ahold 3.538 74.333
Air France - KLM 1.025 35.034
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.775
Allfunds Group 4 1.470
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.836 243.012
AMG 971 133.256
AMS 3 73
Amsterdam Commodities 305 6.689
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 14.994
Apollo Alternative Assets 1 17
Apple 5 381
Arcadis 252 8.772
Arcelor Mittal 2.033 320.693
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.300
Aroundtown SA 1 219
Arrowhead Research 5 9.731
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.093
ASML 1.766 106.826
ASR Nederland 21 4.478
ATAI Life Sciences 1 7
Atenor Group 1 486
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.661
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392